Risk factors associated with 30-day readmission and length of stay in patients with type 2 diabetes Laura M. Enomoto, Deepika P. Pradhan, Meredith Rosenthal, Christopher S. Hollenbeak, Robert A. Gabbay PII: DOI: Reference:

S1056-8727(16)30738-3 doi: 10.1016/j.jdiacomp.2016.10.021 JDC 6881

To appear in:

Journal of Diabetes and Its Complications

Received date: Revised date: Accepted date:

28 June 2016 14 October 2016 17 October 2016

Please cite this article as: Enomoto, L.M., Pradhan, D.P., Rosenthal, M., Hollenbeak, C.S. & Gabbay, R.A., Risk factors associated with 30-day readmission and length of stay in patients with type 2 diabetes, Journal of Diabetes and Its Complications (2016), doi: 10.1016/j.jdiacomp.2016.10.021

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT

NU

SC

RI P

Laura M. Enomoto The Pennsylvania State University College of Medicine Department of Surgery 500 University Drive Hershey, PA 17033 USA Tel #: 717-531-0003 x285544 E-mail: [email protected]

T

Risk factors associated with 30-day readmission and length of stay in patients with type 2 diabetes

PT

ED

MA

Deepika P. Pradhan* The Pennsylvania State University College of Medicine Department of Medicine 500 University Drive Hershey, PA 17033 USA Tel #: 717-531-0003 E-mail: [email protected] *Present Address: Internal Medicine 2112 Harrisburg Pike, Suite 200 Lancaster, PA 17601 USA

AC

CE

Meredith Rosenthal Harvard School of Public Health Health Policy and Management 677 Huntington Avenue Boston, MA 02115 USA Tel #: 617-432-3418 E-mail: [email protected]

Christopher S. Hollenbeak *see corresponding author information Robert A. Gabbay Joslin Diabetes Center One Joslin Place Boston, MA 02215 USA Tel #: 717-309-2470 E-mail: [email protected] Disclaimer: The Pennsylvania Health Care Cost Containment Council (PHC4) is an independent state agency responsible for addressing the problem of escalating health costs, ensuring the

ACCEPTED MANUSCRIPT quality of health care, and increasing access to health care for all citizens regardless of ability to pay. PHC4 specifically disclaims responsibility for any analyses, interpretations or conclusions.

AC

CE

PT

ED

MA

NU

SC

RI P

T

Corresponding Author: Christopher S. Hollenbeak, PhD The Pennsylvania State University College of Medicine 500 University Drive, H151 P.O. Box 850 Hershey, PA 17033-0850 USA Tel #: 717-531-5890 Fax #: 717-531-4464 Email: [email protected]

ACCEPTED MANUSCRIPT 2 ABSTRACT Aims: Patients with Type 2 diabetes mellitus (Type 2 DM) are at greater risk of poor hospital

T

outcomes. The purpose of this study was to determine the impact of Type 2 DM on 30-day

RI P

hospital readmission and length of stay (LOS).

Methods: We studied all inpatient admissions in Pennsylvania during 2011 using data from the

SC

Pennsylvania Health Care Cost Containment Council. Outcomes included 30-day readmission

NU

and inpatient LOS. We estimated the impact of Type 2 DM on readmission and LOS, and identified risk factors for readmission and prolonged LOS.

MA

Results: Among inpatient admissions, patients with diabetes were more likely to be readmitted (AOR=1.17, P